nodes	percent_of_prediction	percent_of_DWPC	metapath
Ibandronate—Blood calcium decreased—Varenicline—nicotine dependence	0.0839	0.0839	CcSEcCtD
Ibandronate—Rash generalised—Varenicline—nicotine dependence	0.0448	0.0448	CcSEcCtD
Ibandronate—Parosmia—Varenicline—nicotine dependence	0.0294	0.0294	CcSEcCtD
Ibandronate—Endocrine disorder—Varenicline—nicotine dependence	0.023	0.023	CcSEcCtD
Ibandronate—Gastrooesophageal reflux disease—Varenicline—nicotine dependence	0.0211	0.0211	CcSEcCtD
Ibandronate—Musculoskeletal pain—Varenicline—nicotine dependence	0.0193	0.0193	CcSEcCtD
Ibandronate—Influenza like illness—Varenicline—nicotine dependence	0.0185	0.0185	CcSEcCtD
Ibandronate—Oesophagitis—Varenicline—nicotine dependence	0.0174	0.0174	CcSEcCtD
Ibandronate—Mouth ulceration—Varenicline—nicotine dependence	0.0172	0.0172	CcSEcCtD
Ibandronate—Hypertonia—Varenicline—nicotine dependence	0.0167	0.0167	CcSEcCtD
Ibandronate—Sleep disorder—Varenicline—nicotine dependence	0.016	0.016	CcSEcCtD
Ibandronate—Deafness—Varenicline—nicotine dependence	0.0155	0.0155	CcSEcCtD
Ibandronate—Injury—Varenicline—nicotine dependence	0.015	0.015	CcSEcCtD
Ibandronate—Renal failure acute—Varenicline—nicotine dependence	0.015	0.015	CcSEcCtD
Ibandronate—Amnesia—Varenicline—nicotine dependence	0.0147	0.0147	CcSEcCtD
Ibandronate—Thirst—Varenicline—nicotine dependence	0.0145	0.0145	CcSEcCtD
Ibandronate—Arthritis—Varenicline—nicotine dependence	0.0142	0.0142	CcSEcCtD
Ibandronate—Osteoarthritis—Varenicline—nicotine dependence	0.0138	0.0138	CcSEcCtD
Ibandronate—Migraine—Varenicline—nicotine dependence	0.0136	0.0136	CcSEcCtD
Ibandronate—Urinary retention—Varenicline—nicotine dependence	0.0131	0.0131	CcSEcCtD
Ibandronate—Abdominal pain upper—Varenicline—nicotine dependence	0.0126	0.0126	CcSEcCtD
Ibandronate—Breast disorder—Varenicline—nicotine dependence	0.0125	0.0125	CcSEcCtD
Ibandronate—Cramp muscle—Varenicline—nicotine dependence	0.0124	0.0124	CcSEcCtD
Ibandronate—Nasopharyngitis—Varenicline—nicotine dependence	0.0124	0.0124	CcSEcCtD
Ibandronate—Gastritis—Varenicline—nicotine dependence	0.0122	0.0122	CcSEcCtD
Ibandronate—Asthma—Varenicline—nicotine dependence	0.0119	0.0119	CcSEcCtD
Ibandronate—Dysphagia—Varenicline—nicotine dependence	0.0119	0.0119	CcSEcCtD
Ibandronate—Bronchitis—Varenicline—nicotine dependence	0.0115	0.0115	CcSEcCtD
Ibandronate—Abdominal discomfort—Varenicline—nicotine dependence	0.0115	0.0115	CcSEcCtD
Ibandronate—Infestation NOS—Varenicline—nicotine dependence	0.0107	0.0107	CcSEcCtD
Ibandronate—Infestation—Varenicline—nicotine dependence	0.0107	0.0107	CcSEcCtD
Ibandronate—Depression—Varenicline—nicotine dependence	0.0106	0.0106	CcSEcCtD
Ibandronate—Stomatitis—Varenicline—nicotine dependence	0.0104	0.0104	CcSEcCtD
Ibandronate—Hepatobiliary disease—Varenicline—nicotine dependence	0.0101	0.0101	CcSEcCtD
Ibandronate—Urinary tract disorder—Varenicline—nicotine dependence	0.00944	0.00944	CcSEcCtD
Ibandronate—Oedema peripheral—Varenicline—nicotine dependence	0.00942	0.00942	CcSEcCtD
Ibandronate—Connective tissue disorder—Varenicline—nicotine dependence	0.0094	0.0094	CcSEcCtD
Ibandronate—Urethral disorder—Varenicline—nicotine dependence	0.00937	0.00937	CcSEcCtD
Ibandronate—Eye disorder—Varenicline—nicotine dependence	0.00894	0.00894	CcSEcCtD
Ibandronate—Cardiac disorder—Varenicline—nicotine dependence	0.00887	0.00887	CcSEcCtD
Ibandronate—Angiopathy—Varenicline—nicotine dependence	0.00868	0.00868	CcSEcCtD
Ibandronate—Immune system disorder—Varenicline—nicotine dependence	0.00864	0.00864	CcSEcCtD
Ibandronate—Mediastinal disorder—Varenicline—nicotine dependence	0.00862	0.00862	CcSEcCtD
Ibandronate—Chills—Varenicline—nicotine dependence	0.00858	0.00858	CcSEcCtD
Ibandronate—Mental disorder—Varenicline—nicotine dependence	0.00838	0.00838	CcSEcCtD
Ibandronate—Malnutrition—Varenicline—nicotine dependence	0.00832	0.00832	CcSEcCtD
Ibandronate—Erythema—Varenicline—nicotine dependence	0.00832	0.00832	CcSEcCtD
Ibandronate—Flatulence—Varenicline—nicotine dependence	0.0082	0.0082	CcSEcCtD
Ibandronate—Dysgeusia—Varenicline—nicotine dependence	0.00815	0.00815	CcSEcCtD
Ibandronate—Back pain—Varenicline—nicotine dependence	0.00805	0.00805	CcSEcCtD
Ibandronate—Muscle spasms—Varenicline—nicotine dependence	0.008	0.008	CcSEcCtD
Ibandronate—Ill-defined disorder—Varenicline—nicotine dependence	0.00772	0.00772	CcSEcCtD
Ibandronate—Anaemia—Varenicline—nicotine dependence	0.00769	0.00769	CcSEcCtD
Ibandronate—Angioedema—Varenicline—nicotine dependence	0.00761	0.00761	CcSEcCtD
Ibandronate—Malaise—Varenicline—nicotine dependence	0.00751	0.00751	CcSEcCtD
Ibandronate—Vertigo—Varenicline—nicotine dependence	0.00748	0.00748	CcSEcCtD
Ibandronate—Palpitations—Varenicline—nicotine dependence	0.00736	0.00736	CcSEcCtD
Ibandronate—Hypertension—Varenicline—nicotine dependence	0.00719	0.00719	CcSEcCtD
Ibandronate—Arthralgia—Varenicline—nicotine dependence	0.00709	0.00709	CcSEcCtD
Ibandronate—Chest pain—Varenicline—nicotine dependence	0.00709	0.00709	CcSEcCtD
Ibandronate—Myalgia—Varenicline—nicotine dependence	0.00709	0.00709	CcSEcCtD
Ibandronate—Anxiety—Varenicline—nicotine dependence	0.00706	0.00706	CcSEcCtD
Ibandronate—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.00704	0.00704	CcSEcCtD
Ibandronate—Discomfort—Varenicline—nicotine dependence	0.007	0.007	CcSEcCtD
Ibandronate—Dry mouth—Varenicline—nicotine dependence	0.00693	0.00693	CcSEcCtD
Ibandronate—Infection—Varenicline—nicotine dependence	0.00675	0.00675	CcSEcCtD
Ibandronate—Shock—Varenicline—nicotine dependence	0.00668	0.00668	CcSEcCtD
Ibandronate—Nervous system disorder—Varenicline—nicotine dependence	0.00666	0.00666	CcSEcCtD
Ibandronate—Skin disorder—Varenicline—nicotine dependence	0.0066	0.0066	CcSEcCtD
Ibandronate—Hyperhidrosis—Varenicline—nicotine dependence	0.00657	0.00657	CcSEcCtD
Ibandronate—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.00619	0.00619	CcSEcCtD
Ibandronate—Insomnia—Varenicline—nicotine dependence	0.00614	0.00614	CcSEcCtD
Ibandronate—Dyspepsia—Varenicline—nicotine dependence	0.00598	0.00598	CcSEcCtD
Ibandronate—Decreased appetite—Varenicline—nicotine dependence	0.00591	0.00591	CcSEcCtD
Ibandronate—Gastrointestinal disorder—Varenicline—nicotine dependence	0.00586	0.00586	CcSEcCtD
Ibandronate—Fatigue—Varenicline—nicotine dependence	0.00586	0.00586	CcSEcCtD
Ibandronate—Pain—Varenicline—nicotine dependence	0.00581	0.00581	CcSEcCtD
Ibandronate—Constipation—Varenicline—nicotine dependence	0.00581	0.00581	CcSEcCtD
Ibandronate—Feeling abnormal—Varenicline—nicotine dependence	0.0056	0.0056	CcSEcCtD
Ibandronate—Gastrointestinal pain—Varenicline—nicotine dependence	0.00556	0.00556	CcSEcCtD
Ibandronate—Urticaria—Varenicline—nicotine dependence	0.0054	0.0054	CcSEcCtD
Ibandronate—Abdominal pain—Varenicline—nicotine dependence	0.00537	0.00537	CcSEcCtD
Ibandronate—Body temperature increased—Varenicline—nicotine dependence	0.00537	0.00537	CcSEcCtD
Ibandronate—Hypersensitivity—Varenicline—nicotine dependence	0.00501	0.00501	CcSEcCtD
Ibandronate—Asthenia—Varenicline—nicotine dependence	0.00487	0.00487	CcSEcCtD
Ibandronate—Pruritus—Varenicline—nicotine dependence	0.00481	0.00481	CcSEcCtD
Ibandronate—Diarrhoea—Varenicline—nicotine dependence	0.00465	0.00465	CcSEcCtD
Ibandronate—Dizziness—Varenicline—nicotine dependence	0.00449	0.00449	CcSEcCtD
Ibandronate—Vomiting—Varenicline—nicotine dependence	0.00432	0.00432	CcSEcCtD
Ibandronate—Rash—Varenicline—nicotine dependence	0.00428	0.00428	CcSEcCtD
Ibandronate—Dermatitis—Varenicline—nicotine dependence	0.00428	0.00428	CcSEcCtD
Ibandronate—Headache—Varenicline—nicotine dependence	0.00426	0.00426	CcSEcCtD
Ibandronate—Nausea—Varenicline—nicotine dependence	0.00404	0.00404	CcSEcCtD
